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ABSTRACT 
We conducted a national online survey about health care experiences associated with 
digital  communication of prescription drugs. 46 percent of the sample (265 adults) found 
information about prescription drugs during their online search in the last 12 months.  
 
40 percent of respondents agreed they didn’t find exhaustive information about risks and 
benefits while 52 percent agreed it helped in following their physician’s indications and 
advise. 
 
 Among the 84 percent of the sample who had a physician visit during which health 
information found online was discussed, 84 percent received a drug prescription with only 
17 percent being the same drug found on internet, 74 percent was sent  to a specialist and 
80 percent received a diagnostic test prescription.   
 
More than half also reported actions taken by their physician other than prescribing the 
drug brand found online.  
 
20 percent respondents states that info found on the prescription drug in Internet reduced 
his/her trust in the physician while 41 percent states it helped in his/her communication 
with physician.  
 
Despite concerns about online health communication’s negative consequences, we found 
no differences in health effects between patients who took “advocated”/”mentioned” drugs 
and those who took other prescription drugs. 
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“There is now widespread agreement among both the general population and health professionals that a good deal of 
disease is self-inflicted, the product of our own imprudent behavior. The premise that individuals contribute significantly 
to their own ill health or premature death appears unassailable in view of the mounting evidence relating various 
personal habits and lifestyle choices, such as poor nutrition, smoking, alcohol and drug abuse, failure to wear seat belts, 
and unsafe sexual practices, to major causes of morbidity and mortality. 
While it is generally accepted that each of us is, to a certain extent, "dangerous to our own health," there is far less 
agreement on what can or should be done about making people less foolish. In particular, there is the question of how far 
government should go in fashioning lifestyles to minimize the physical and mental harm we inflict upon ourselves and 
others in society through risky personal choices. Where does personal choice and collective responsibility begin? How 
we reconcile two of our most prized social values, personal freedom and good health?” 
 
Howard M.Leichter, Free to be Foolish
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1. GENERAL INTRODUCTION 
In this introduction we first outline the context to this thesis recalling main definitions of 
health communications and marketing. Second  we describe the problem area and 
subsequent research focus. From there, we define our main objective as well as our 
research questions. We conclude this introduction with an overview of the organization of 
the thesis. 
1.1 CONTEXT AND SCENE SETTING 
Adding to Bill Gates’ quote, Charles Grant stated that  “Communica- 
tion is an essential component of health care”. Although this quote  
may demonstrate the thoughtful nature of  health communication, it is  
also well understood that health communication is elusive and complex –  
in concept and definition, in creation/development and delivery as well as  
in measurement and management. This is further complicated when looking at health 
communication in relation to healthcare outcomes (as opposed to consumer goods 
communication) especially in business-to-consumer context (as opposed to a business-to-
business environment). 
To elucidate the wider context of this thesis, before moving on to defining health 
communication and describing its role in shaping and producing positive or negative 
healthcare outcomes, we start by highlighting the importance of ethical health 
communication. 
 
“If you get health, then you 
have opportunity for literacy. 
Health first, then literacy. Once 
you have literacy, then you 
have a chance to bring in the 
new tools of communication. 
Let people reach out and have 
access to the latest advances”. 
Bill Gates 
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THE ETHICS OF HEALTH COMMUNICATION 
Health communication is a two-way process and takes place among biomedical scientists, 
between scientists and medical practitioners, between health professionals and the mass 
media, and between the mass media and the public. Being a means of combating disease 
and improving or protecting health, it should be conducted in accordance with certain 
ethical principles, namely those of beneficience, non-maleficience, respect for personal 
autonomy, and justice. 
Excessive health information may undermine the public’s capacity to absorb essential 
advice and respond to it in a rational way. Journalists and communication professionals 
who communicate medical information should not compromise ethical principles for 
commercial purposes. 
Good journalists and communication professionals recognize the limitations of facts taken 
out of context and are aware of their potential for misinformation and harm and out of the 
ethical shortcomings of communicating them. Concealing or misrepresenting a context 
may take the form of failing to identify a research sponsor, for instance in the event of 
studies on lung cancer sponsored by the tobacco industry. 
An obligation to benefit some people has to take account of any associated risk of harming 
others. The principle of beneficence implies providing net benefit, and health 
communicators should therefore make harm/benefit analyses. To do this they have to 
understand, weigh and specify the harm that is being risked and the likely benefits of an 
item of information. Assessments of harm and benefit may vary between members of the 
public, journalists, health communicators and doctors. Harm may result from a  
12 
 
 
 
misinformed decision as happened when the uptake of influenza vaccination declined in  
Italy following unbalanced and inaccurate reporting of the risks associated to the 
administration of the Novartis vaccine in October 2012. Journalists should try to anticipate 
the responses of their readerships and audiences, who should be informed about 
opposing views. Clearly, communicating information about harm and benefit in such a way 
as to respect the autonomy of individuals and their right to make up their own minds is 
ethically distinct from presenting it in a manner believed by a campaigning communicator 
to be beneficial. All persons involved in health communication have an ethical 
responsibility to do no harm to the public. Journalists’ loyalties should be to their readers 
rather than their sources.  Where there is a risk of harm to the public, journalists and 
health communicators should take the public’s side. In some countries, such as France, 
medical Journalists have a written code of ethics. Elsewhere, for instance in the United 
States, ethical issues are decided on a case-by-case basis. In Italy, medical journalists 
don’t  have a written code of ethics. 
There is no written code of ethics for health communicators in no country, including Italy. 
Many countries have regulations requiring the pharmaceutical industry to communicate 
information about the safety of its products to consumers. In Italy DTCA is regulated by the 
DL 24 aprile 2006, n. 219 - TITLE VIII . Below we recall the articles more strictly related to 
the topic of our thesis. 
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Art. 113 “For the purposes of this Title, "advertising of medicinal products' shall include 
any information, activity or exhortation, designed to promote the prescription, supply, sale 
or consumption of medicinal products”  
 
Art. 114: 1. It is forbidden any kind  of advertising of a drug product for which no marketing 
authorization  (AIC) has been issued a in accordance with this Decree, Regulation (EC) n. 
726/2004 or other binding Community provisions; 2. All parts of the advertising of a 
medicinal product must comply with the information listed in the summary of product 
characteristics; 3. Drug advertising: a)must encourage the rational use of the medicinal 
product, by presenting it objectively and without exaggerating its properties; b) not be 
misleading;  
Art. 115 . 1. The medicinal products, their composition and their therapeutic target, are 
designed and manufactured for use without the intervention of a physician for diagnosis, 
prescription or monitoring during treatment and, if necessary, with the advice of the 
pharmacist can be advertised to the public; 2. It is forbidden to advertise to the general 
public medicinal products which can be supplied only by prescription or contain 
psychotropic or narcotic substances, in derogation from that prohibition the Ministry of 
Health may authorize vaccination campaigns promoted by pharmaceutical companies; 3. It 
is forbidden the distribution of medicinal products  to the general public for promotional 
purposes; 4. Except as provided in the second part of paragraph 2 of this Article, it is 
forbidden advertising to the general public of medicinal products, whose dispensation 
burden, even if not entirely, is on the National Health Service, as well as' medicinal 
products referred to in subparagraphs a) , b) and c) of Article 3, paragraph 1, and Article 5; 
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5. In printed publications, radio and television broadcasts and messages for advertising, 
however, made public, it is forbidden to show images of a medicinal product or its name in 
a context that can facilitate the consumption of the product. 
 
 
Art.118: 1. No advertising of medicinal products to the public can be carried out without 
the authorization of the Ministry of Health, with the exception of advertising in newspapers 
or periodical which, provided the provisions of Article 116 paragraph 1, only reproduce in 
its entirety and without modification  the indications, contraindications, precautions for use, 
interactions, special warnings, adverse reactions described in the package insert, with the 
addition of a picture or a graphic representation of the outer packaging of the medicinal 
product ; 2. The authorization is issued by the Ministry of Health, in consultation with the 
Committee of Experts referred to in Article 201 of the Consolidated Law Health, the Royal 
Decree of 27 July 1934, n. 1265, as amended. 
In order to have a better understanding of the regulation  we must distinguish between 
advertising and information. 
Information: raise awareness, give information, provide data about people or things. It 'a 
personal right which is connected with the broader law of development of the human 
person (Article 3 of the Italian Constitution) and of expression. 
Advertisement: adv activities to promote commercial purposes at the entire community of 
consumer knowledge and the favorable reception of certain products and services, in 
order to influence the behavior of individuals. 
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In addition to the DL 24 aprile 2006, n. 219 - TITLE VIII , drug advertising is regulated by 
the Code of Advertising Self-Regulation (art. 25) and by the Code of Professional Conduct 
Farmindustria  - February 22, 2012 - Advertising in newspapers and magazines  - 2.16  
which states that “In the ambit of newspaper and magazine advertising, companies must 
comply with the rule of transparency and thereby accept, as an essential criterion, the net 
separation between information and advertising and hence guaranteeing the reader to be  
 
immediately able to recognize a promotional message, whatever its editorial or columnar 
layout. 
This diversity of controls perhaps gives good grounds for drawing up an international 
written code of ethics for the communication to the public of information pertaining to 
health. 
With the advent of new media the number of people seeking health information online 
has tremendously increased but a lot needs to be done in the direction of developing 
national/international ethical standards. 
In general, the most useful type of web site for patients with a specific disease is a 
commercial site that provides in-depth information on a wide array of regional specific 
health issues. It should be financially nonbiased, and it should meet high ethical standards 
developed for information transfer (Ullrich, Jr. et al 2002),. 
A standard of ethics for the dissemination of patient specific health information has not 
been universally accepted or imposed on the myriad of web portals available on the 
Internet. To address this issue, several organizations are trying to develop a standard 
code of ethics for the World Wide Web health care industry. Specifically, Hi-Ethics 
(Healthcare Internet Ethics), Health on the Net Foundation, and the Internet Healthcare 
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Coalition’s E Health Ethics Initiative have combined to develop an E-Health Code of 
Ethics. 
These organizations have agreed that health web sites, at the minimum, should:  
 provide health information that is secure and trustworthy.  
 clearly identify online advertising and disclose sponsorships or other financial 
relations that significantly 
 
 affect the site’s content or services. 
 keep personal information private and secure and employ special precautions for 
any personal health information. empower consumers to distinguish online health 
services that follow their principles from those that do not. 
At this writing, not all of these organizations screen or verify adherence to such a code of 
ethics. Currently, there simply are not sufficient resources or will among the industry to do 
this. 
Some professional medical societies also are beginning to develop their own code of 
ethics, and to screen health information web sites as a service for their members. 
As an example, the Journal of the American Medical Association (JAMA) has developed 
an extensive code of ethics, which is published on the web site of the American Medical 
Association (AMA). 
In essence, patient medical education sites should at least provide pertinent information 
necessary for users to use in making an informed judgment about the accuracy of the 
information on the site and any potential source of bias. 
For physicians to choose a web site most useful to their patients without needing regularly 
to scan more than the 25,000 available health web sites available, they may rely on web 
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review services that frequently audit web site quality  and ethics. One service that does 
just this is provided by the National Institutes of Health (www.medlineplus.gov). 
This service provides free access to information collected from its own sources, other 
government organizations, professional societies, universities, and other high-quality 
sources. All of the sites have been rigorously screened, and recommendations are 
updated on a regular basis. This service ensures that the sites adhere to ethical standards 
and are of high quality. 
 
 
Although MEDLINEplus is fairly new to the electronic arena, it (along with the rest of 
www.nih.gov) is already the second most popular health care Internet site.6 MEDLINEplus 
is an excellent resource for guiding physicians to health web sites that focus on issues 
pertinent to their needs. Similarly, The Department of Health and Human Services 
provides an Internet service (www. healthfinder.gov) that screens health care sites and 
links to those that meet its ethical and quality guidelines. 
A high-quality search engine also can be a good starting point for finding reliable health 
web sites. Most search engines  on the Internet use automated “spiders” and other 
technology to find and rank web sites, but unfortunately do not screen for quality, content, 
and ethical standards. 
Google (www.google.com) was recently deemed the best search engine by the Wall Street 
Journal. 
The distinction between communication and marketing is poorly understood throughout the 
field of public health. They are often seen as interchangeable. Maibach et al. (2007)  
believe, however, that the concepts are distinct and that the distinctions are meaningful for 
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public health. Each method offers a different and complementary approach through which 
to advance public health objectives. 
Healthy People 2010 – a publication that presents the current U.S. federal health 
objectives – defined health communication as "the art and technique of informing, 
influencing and motivating individual, institutional and public audiences about important 
health issues." This definition is laudable for its inclusion of the full range of audiences 
implied by an ecological framework. Borrowing from the strengths of each definition, we  
 
define health communication as "the production and exchange of information to inform, 
influence or motivate individual, institutional and public audiences about health issues." 
The American Marketing Association defines marketing as "an organizational function and 
a set of processes for creating, communicating, and delivering value to customers and for 
managing customer relationships in ways that benefit the organization and its 
stakeholders." Inherent in this definition is the notion of the marketing exchange. Marketing 
and communication do overlap, both in concept and in how they are applied in public 
health. Marketing communication, or promotion, involves the use of communication to 
support the marketing process. The definitions above were provided with the specific intent 
of clarifying confusion in the literature where communication has often been mistaken for 
marketing, and vice versa.  
One metric by which to gauge the relevance of communication and marketing to public 
health practice is the extent to which they are capable of creating – or contributing to – 
beneficial changes in each of the five fields of influence. Figure 1 illustrates our contention 
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that communication and marketing each have potential to contribute to beneficial changes 
in all five fields of influence, and Figure 2 identifies the specific uses, or roles, of 
communication and marketing as they have been explored in public health to date.  
 
Figure 1 - Communication and marketing potential to contribute to beneficial changes 
 
 
Figure 2. Specific uses, or roles, of communication and marketing in public health 
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The type and availability of communication vehicles that can be used to convey public 
health information to individuals has grown dramatically over time. Some of these 
communication vehicles – e.g., brochures, small group counselling sessions, interactive 
DVDs, email and text messages – are well-suited to providing information to individuals on 
a one-to-one, or a one-to-few, basis. These communication vehicles can be effectively 
tailored to respond to individual attributes of the person receiving the information. Other 
communication vehicles – e.g., TV, radio, newspapers, movies, websites – are well-suited 
to providing information on a one-to-many, or mass, basis. It is worth noting, however, that 
when we use communication vehicles on a "one-to-many" basis, we are typically 
attempting to influence individual-level attributes of people (e.g., self-efficacy) EN MASS , 
rather than attempting to influence attributes of the population per se (e.g., collective 
efficacy). The latter use of communication, as explained below, is a relatively unexplored 
opportunity in public health.  
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CONTEXT 
Until just a few years ago advertising of prescription drugs was aimed almost exclusively at 
physicians and other health professionals. Although physician drug detailing (in-person 
visits by drug company representatives) has been criticized for exerting undue influence 
on prescribing habits, physicians’ training and experience equip them, at least in theory, to 
process and evaluate advertisers’ claims and make informed prescribing decisions for their 
patients. 
The near-exclusive focus on physicians changed in the late 1990s,when the 
pharmaceutical industry increased its use of direct-to-consumer advertising (allowed in 
USA and Scandinavia) while in Europe,  DTC adv was introduced using a “disease 
awareness” model: disease  information/education as a catalyzer to both engage 
consumers and create a dialogue/relationship between company (corporate brand) as the 
owner of the product brand and the consumer as end user or carer. 
 
Disease awareness approach is recognized as follows: 
 Communication process, non an event 
 Information/education instead of adv/promotion 
 Built around a disease or medical condition, not a specific treatment or a product brand 
 
With the advent of Internet and the increase of online health information seeking, 
European  and Italian customers, mostly from medium-high social/educational level target, 
are increasingly exposed to DTC adv.   
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The great popularity of Social Media sites has definitely added a new dimension to the 
discipline of marketing and health communication. Social Media has taken its place on the 
list along with traditional media such as TV, Print, Radio, Outdoor, WOM and more 
recently Digital. And out of all the marketing options Social Media offers, Advocacy is 
being heralded as the “holy grail”. 
Prior to the arrival of the internet,  an individual may have recommended a brand to a 
handful of friends, they can now recommend (or advocate) the same brand to  hundreds of 
friends and followers, or millions via forums, blogs and customer reviews. This is why 
social media is such a useful marketing and communication tool: a brand message can be 
disseminated in a very cost efficient way. 
Advocacy can be defined in many ways: to recommend, to provide references, to be an 
ambassador for a brand.  Plainly put Advocacy is people talking nicely about an 
organisation and recommending what the organisation has to offer to other people. 
There are numerous studies which tell us that I trust real people (this is true both of friends 
and of any other consumer we read online) more than we trust the “big corporations” 
talking to us via advertising. With the growing popularity of Social Media sites, the answer 
to this dilemma has become obvious: Advocacy.    
Individuals broadcasting a brand message to their peers has proven to be an extremely 
effective marketing strategy- there are real examples of brands such as Merck which has 
launched a Facebook campaign to maximize the effect of communication for its vaccine 
brand Gardasil. More than 50.000 fans have joined the Gardasil Group in USA 
(http://news.yahoo.com/women-steps-prevent-cervical-cancer-210417326.html). This 
successful  online campaign  uses surveys, stories, cards, banners and more to promote  
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and provide information about the brand (USA) and papilloma virus  (Italy/Europe) 
(http://scienzaesalute.blogosfere.it/2011/06/papilloma-virus-sintomi-e-precauzioni.html).  
Advocacy is better than advertising because of the trustworthiness of the advocate or 
“ambassador”. It becomes more efficient when the ambassadors are high influencers, 
opinion leaders, people with gravitas, but it is not limited to these kinds of people. An 
organisation will be pleased to have anyone talking positively about them, be they high 
influencers or not. Advocacy can drive sales, it can defend current customer relationships 
and above all it can build brand equity.  
The role of health advocacy is to influence governments and national/international 
agencies in beneficient and health-promoting ways, and to raise the profile of health-
promoting organizations, ensuring that their voices are heard and taken note of (IUHPE, 
1999). Both Health promotion and public health are currently involved in a form of self-
advocacy, obliged to re-invent themselves as “investments” in times of tough global 
competition for finite resources (Labonte, 1999; WHO, 1999). Ironically, the lack of 
concrete and universally accepted definitions for the term “health” and “health promotion” 
that so irritates critics is probably the factor which provides sufficient flexibility and scope 
for such reinvention. Advocacy for health therefore fulfils two functions: it is both a form of 
practice and a useful strategic tool for a discipline which has to be self-promoting as well 
as health-promoting in order to survive in the demanding contemporary environment of 
national and international health work (Carlisle, 2000). 
In May 2012, Facebook logged its 900 millionth user. It is estimated that 80 percent of the 
world’s online population use social networks on a regular basis. In the United States, the  
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share of total online time spent on social networking platforms more than doubled from 
January 2008 to January 2011, from 7 percent to 15 percent.  
The latest challenge for health communication in the 21st century is web 2.0. 
 Although modest at first, spending on web 2.0 in health communications is increasing 
following the increasing trend in consumers use of internet to seek health information. 
A survey conducted in 2010 by Doctor's Guide Publishing has, in fact, shown that 30 
percent of the top 50 pharmaceutical companies have not activated any kind of social 
media presence, while only 11 and 20 of the top 50 pharmaceutical companies have at 
their disposal an authorized channel respectively, YouTube and Twitter. Their limited use 
was also evidenced by the lack of investment made by the pharmaceutical companies, 
with only 4 percent (more than $ 4 billion) spent in the promotion on the Internet, which 
was a small part dedicated to social networks and social media. 
The reason for this limited presence was and, probably, is largely dictated by the absence 
of guidance from the Food and Drug Administration to regulate the use of these 
information channels and that relate to the content of the discussions on drugs in social 
networks. The guidelines governing the information directly to the public via the traditional 
media (print, radio and television) necessitates that it is clear which risks to which 
undergoing patients taking a particular drug and the side effects it causes. In social 
networks and social media content, however, are supplied directly by the citizens through 
their contributions and comments. 
It is therefore impossible to test the rules that apply to traditional media.  
Based on the CENSIS data (October 2012), 32 percent of the respondents said they use 
the internet to search health information. More specifically, 90 percent look for information  
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on specific diseases, 59 percent look for information on physicians and healthcare 
providers, while 14 percent participate in forums, communities, other ways of exchanging 
information and experiences among peers. 
It is interesting to notice an increase registered in the number of aged people using 
internet from 56,4 percent in 2006 to 73,6 percent in 2012 mostly if we compare the data 
with the  mean value (respectively 64,3 percent in 2006  and 73,2 percent in 2012). 
Based on a recent survey from GfK EURISKO, 46% of internauts seeked health 
information in Internet in the last 3 months. They used Internet: 
 To confront and share information/opinions/experiences with peers (17%): 
o Friends/relatives (26%) 
o Physician (23%) 
o Patients affected by the same disease (16%) 
o Pharmacist (8%) 
 To seek health information (42) on : 
o Diseases/health discomfort (36%) 
o Drug/treatment products  and solutions (23%) 
o Healthcare providers (21%) 
 
The use of blogs and forums to discuss their health problem with peers registered a 
significant increase from 2% in 2011 to 17% in 2012. 
Based on a survey from GfK EURISKO (0ctober 2011;  Italian population 14 years old  up, 
n= 4.000), 51 percent of the Italian population connected to the Internet in the last 3 
months,35 percent  searched for health information. 13 percent users ( around 2.3 million  
 
26 
 
 
people) was over 54 years old (last 3 months); 18 percent used the Internet to search for 
health/medical information.  
 
They used the Internet to get: 
 Health information (35%) 
 Disease information (25%) 
 Treatment/drugs information (13%) 
 Health providers/Physicians (10%) 
 Discuss with other people through blogs/forums (2%) 
 
They use information to: 
 Discuss with physician (54%) 
 Discuss with pharmacist (31%) 
 Decide which drug to purchase (17%) 
